A recent press release from NewYork-Presbyterian Hospital is reporting that its surgical team has performed the first in New York City implantation of an abdominal aortic stent graft, a device “designed to treat a complex form of abdominal aortic aneurysms in which the weakened, enlarged vessel wall is too close to the arteries leading to the kidneys. These complex aneurysms cannot be safely treated with currently available aortic stent grafts and would otherwise require major surgery. Without treatment, patients with aortic aneurysms are at risk for sudden death.”
We have contacted a rep for Cook Medical, the maker of Zenith® Fenestrated AAA Endovascular Graft, for an explanation about this custom made device, and here’s what we got in response:
Cook’s fenestrated endograft is the first in the world to incorporate tailored openings – either as semi-circular scallops or full-circular openings called fenestrations – in the top section of the endograft. This allows the self-expanding fabric-covered stent-graft to treat aortic and aortoiliac aneurysms extending close to the renal and superior mesenteric arteries, which are then stented to reduce the risk of restricting or blocking critical blood flow to the kidneys and bowel. Each fenestrated device is custom-made to suit individual patients’ anatomy by Cook’s endograft manufacturing division in Australia.
Cook’s Zenith Fenestrated AAA Endovascular Graft is an investigational device not available for sale in the U.S. It has regulatory approval for sale in Canada, Europe, Australia and New Zealand, and other major markets.
Product page: Zenith® Fenestrated…
